Dow Up 0.36% Nasdaq Up 0.12%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
0.90 Down 0.01(1.37%) Aug 21, 4:00PM EDT
Prev Close:0.91
Open:0.94
Bid:0.81 x 1000
Ask:1.01 x 1000
1y Target Est:3.50
Beta:0.93
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:0.90 - 0.94
52wk Range:0.65 - 4.00
Volume:208,078
Avg Vol (3m):693,052
Market Cap:49.48M
P/E (ttm):N/A
EPS (ttm):-0.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMUC

Comparison

Symbol% ChgMkt Cap
IMUCDown 1.37%49.48M
AGENDown 2.19%195.56M
DNDNDown 0.37%209.05M
STMLDown 0.99%142.28M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback